Stefan H Hohnloser

9PUBLICATIONS
61CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)Gene and molecular therapyMolecular targetsAutonomous agents and multiagent systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 31, 2025
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.

Andre Lamy, Roopinder K Sandhu, Wesley Tong

|Apr 28, 2025
Dronedarone provides effective early rhythm control: post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria.

Paulus Kirchhof, A John Camm, Harry J G M Crijns

|Mar 30, 2025
Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology.

Jose L Merino, Juan Tamargo, Carina Blomström-Lundqvist

|Jun 12, 2023
Indications for mexiletine in the new ESC guidelines and beyond.

Mate Vamos, Elod-Janos Zsigmond, Stefan H Hohnloser

|Apr 11, 2023
Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.

Alexander P Benz, Stefan H Hohnloser, John W Eikelboom

Pageof 2